Research map: Vitamin D decreases tumor cell growth and invasiveness in primary malignant bone tumors in vitro
Back to the article
Papers in this map
- Osteosarcoma: a comprehensive review · Amirhossein Misaghi · 2018 · 528 citations · Cited by this paper
- Post-operative survival and use of systemic therapy in metastatic long-bone disease: 12 years of institutional experience · 2026 · Related
- Directed cell invasion and migration during metastasis · Jose Javier Bravo‐Cordero · 2011 · 476 citations · Cited by this paper
- Risk of fracture among lung cancer survivors by cancer treatment modality: A population-based retrospective cohort study · 2026 · Related
- Vitamin D and DBP: The free hormone hypothesis revisited · Rene F. Chun · 2013 · 449 citations · Cited by this paper
- Assessing the mechanism of osteosarcoma induced by long-term PET exposure: prediction from combined network toxicology, machine learning and molecular docking · 2025 · Related
- The vitamin D-responsive element in the human osteocalcin gene. Association with a nuclear proto-oncogene enhancer. · Keiichi Ozono · 1990 · 317 citations · Cited by this paper
- Opinion statement regarding the use of post-operative radiotherapy after surgery for pathological fractures of the long bones: An answer to the points raised regarding methodology and analysis · 2026 · Related
- Cloning of the human 1α,25-dihydroxyvitamin D-3 24-hydroxylase gene promoter and identification of two vitamin D-responsive elements · Kai-Shun Chen · 1995 · 287 citations · Cited by this paper
- LL-37 inhibits osteosarcoma progression by suppressing SQLE-mediated cholesterol synthesis via the PTEN/AKT/mTOR pathway · 2026 · Related
- Ewing Sarcoma—Diagnosis, Treatment, Clinical Challenges and Future Perspectives · Stefan K. Zöllner · 2021 · 279 citations · Cited by this paper
- Clinically aligned whole-body MRI segmentation of skeletal metastases via Supervised Anatomical Pretraining · 2026 · Related
- RORα and ROR γ are expressed in human skin and serve as receptors for endogenously produced noncalcemic 20‐hydroxy‐ and 20,23‐dihydroxyvitamin D · Andrzej T. Slominski · 2014 · 270 citations · Cited by this paper
- Doxorubicin enhances adipogenesis in an FGF2-dependent manner and induces a tumour-promoting secretory phenotype · 2026 · Related
- Evidence for auto/paracrine actions of vitamin D in bone: 1a‐hydroxylase expression and activity in human bone cells · M. Driel · 2006 · 217 citations · Cited by this paper
- Mri-based habitat and peritumoral radiomics for predicting the proliferative activity of stromal cells in giant cell tumor of bone · 2025 · Related
- Altered Pharmacokinetics of 1α,25-Dihydroxyvitamin D3and 25-Hydroxyvitamin D3in the Blood and Tissues of the 25-Hydroxyvitamin D-24-Hydroxylase (Cyp24a1) Null Mouse · 園子 増田 · 2004 · 182 citations · Cited by this paper
- Risk factors and clinical impact of bone pain in patients with multiple myeloma – A prospective interdisciplinary study · 2026 · Related
- Molecular characterization of commonly used cell lines for bone tumor research: A trans‐European EuroBoNet effort · Laura Ottaviano · 2009 · 180 citations · Cited by this paper
- Malignant and metastatic giant cell tumors of bone; clinical course of primary or secondary malignant and pulmonary metastatic variants · 2025 · Related
- Differential and Overlapping Effects of 20,23(OH)2D3 and 1,25(OH)2D3 on Gene Expression in Human Epidermal Keratinocytes: Identification of AhR as an Alternative Receptor for 20,23(OH)2D3 · Andrzej T. Slominski · 2018 · 121 citations · Cited by this paper
- Vitamin D signaling is modulated on multiple levels in health and disease · Regina Ebert · 2006 · 118 citations · Cited by this paper
- 1,25-Dihydroxyvitamin D3 decreases human prostate cancer cell adhesion and migration · Victoria Sung · 2000 · 116 citations · Cited by this paper
- CYP24, the enzyme that catabolizes the antiproliferative agent vitamin D, is increased in lung cancer · Robert A. Parise · 2006 · 110 citations · Cited by this paper
- CYP24A1 Is an Independent Prognostic Marker of Survival in Patients with Lung Adenocarcinoma · Guoan Chen · 2010 · 110 citations · Cited by this paper
- Primary malignant bone tumors—recent developments · Meera Hameed · 2011 · 98 citations · Cited by this paper
- Chondrosarcoma · Robert C. Weinschenk · 2021 · 90 citations · Cited by this paper
- PTH, FGF-23, Klotho and Vitamin D as regulators of calcium and phosphorus: Genetics, epigenetics and beyond · Ignacio Portales‐Castillo · 2022 · 86 citations · Cited by this paper
- 1α,25-Dihydroxyvitamin D3 inhibits the invasive potential of human breast cancer cellsin vitro · Christina Mørk Hansen · 1994 · 83 citations · Cited by this paper
- Vitamin D Receptor–Dependent 1α,25(OH)2 Vitamin D3–Induced Anti-Apoptotic PI3K/AKT Signaling in Osteoblasts · Xiaoyu Zhang · 2008 · 78 citations · Cited by this paper
- AKT Pathway is Activated by 1,25-Dihydroxyvitamin D3 and Participates in its Anti-Apoptotic Effect and Cell Cycle Control in Differentiating HL60 Cells · Yingyu Zhang · 2006 · 76 citations · Cited by this paper
- CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer · Hongyan Sun · 2015 · 66 citations · Cited by this paper
- Primär maligne Knochentumoren · Rüdiger von Eisenhart‐Rothe · 2011 · 53 citations · Cited by this paper
- Antiapoptotic action of 1α,25-dihydroxyvitamin D3 in primary human melanocytes · Bettina Sauer · 2003 · 50 citations · Cited by this paper
- CYP24A1-induced vitamin D insufficiency promotes breast cancer growth · Makoto Osanai · 2016 · 48 citations · Cited by this paper
- Differential effects of 1,25-dihydroxyvitamin D3-analogs on osteoblast-like cells and onin vitro bone resorption · Gert-Jan C.M. van den Bemd · 1995 · 43 citations · Cited by this paper
- CYP11A1‑derived vitamin D hydroxyderivatives as candidates for therapy of basal and squamous cell carcinomas · Andrzej T. Slominski · 2022 · 38 citations · Cited by this paper
- Impact of CYP24A1 overexpression on growth of colorectal tumour xenografts in mice fed with vitamin D and soy · Julia Höbaus · 2015 · 34 citations · Cited by this paper
- Inhibition of MG-63 cell cycle progression by synthetic vitamin D3 analogs mediated by p27, Cdk2, cyclin E, and the retinoblastoma protein · Sanna Ryhänen · 2003 · 33 citations · Cited by this paper
Source: OpenAlex (CC0)